Description:
OPD Points: 10
The Certificate in Psychedelic-Assisted Therapies (CPAT)™ by Mind Medicine Australia (MMA) is a part online and part face-to-face professional training that provides registered healthcare professionals with the knowledge and skills to safely and effectively administer psychedelic-assisted therapies (PAT) in clinical settings. Over 500 clinicians have trained with us including 68 Psychiatrists, 120 Psychologists, and 71 Psychotherapists and Counsellors.
This program is both for prescribing psychiatrists, as well as other mental health professionals who will be delivering the treatment as part of a multidisciplinary team.
The training is delivered by a world-class faculty made up of global leaders in the field. It teaches best practice for the delivery of PAT, with a focus on psilocybin, MDMA and ketamine-assisted therapy. These are the three psychedelic medicines with regulatory approval in Australia.
Therapists: The course will prepare appropriately qualified and experienced healthcare professionals with the skills and knowledge necessary to safely and effectively support patients undergoing PAT as primary or secondary therapists. Note that the ability to practice as a primary therapist in PAT is largely dependent on prior relevant clinical experience in psychotherapy.
Training focuses on evidence-based, standardised approaches to PAT that may be integrated with clinicians’ existing psychotherapeutic experience and clinical practice. The course includes a combination of face-to-face and online learning and self-study. It is delivered over 14 weeks of online learning and a 6-day full-time, face-to-face residential workshop. The main psychedelic medicines this course focuses on are MDMA, psilocybin and ketamine.
Training of prescribers and therapists occurs together, reflective of the holistic team approach that characterises PAT. In previous iterations of the course, learners have given positive feedback specifically about the value of training together. However, whilst the curriculum is the same for all learners enrolled, in recognition of the unique roles and levels of responsibility of prescribers and therapists, assessment tasks differ for prescribers and therapists and serve to differentiate the CPAT award into two distinct awards: the CPAT- Prescriber and the CPAT-Therapist. Only psychiatrists and medical practitioners will be eligible to complete the assessment for Prescribers and be awarded the CPAT-Prescriber. The awards of CPAT-Prescriber and CPAT-Therapist are dependent on successful completion of all assessment items.
Key Learning Objectives / Outcomes:
At the end of this course, learners should be able to:
Describe the history and development of clinical evidence-based approaches to psychedelic assisted therapy (PAT).
Apply evidence-based PAT protocols for the safe treatment of appropriate mental health conditions, reflective of their role as Prescriber and/or Therapist, clearly delineating roles and responsibilities of clinicians/therapists involved.
Apply knowledge of the concept of inner healing intelligence, the relationship between trauma and mental health disorders, non-materialist perspectives of mental health disorders, altered states of consciousness and mystical experiences to the delivery of PAT.
Apply psychotherapeutic approaches and clinical tools for facilitating preparation and integration in PAT based on an understanding of various psychological models.
Communicate clearly with patients from diverse backgrounds about and during all phases of PAT, including ensuring informed consent.
Describe the regulatory framework around psychedelic medicines in Australia.
Critically evaluate the scientific evidence base for the use of PAT in a range of mental health conditions, including their efficacy and safety.
Argue and clearly communicate the ethical issues, safety considerations and risks involved with PAT and appropriately manage patient experiences including challenging experiences and adverse events associated with psychedelic medicines.
Reflect on desirable qualities for working in PAT and how these apply to self, including areas of development.
Prescribers only: complete an application to an HREC to become an Authorised Prescriber of psilocybin for treatment-resistant depression and MDMA for PTSD (including documenting PAT treatment protocols).
Assessment:
Presenter / Provider:
See attached Course Faculty Document.
Presenter Qualifications:
See attached Course Faculty Document.
See attached Course Faculty Document.
Start / End Date
Times:
Start:
End:
Course Duration:
Course Hours:
Registration Instructions:
Registration is available through the CPAT Website. Upon processing your application, you will receive an invitation to schedule an interview with our course coordinator, Scott Edwards. Once successful, you will be invited to complete the Student Agreement and submit the initial or full course fees (with financial assistance options available). Upon completion, your enrolment in the CPAT Course will be confirmed.
